The patient-centered medical home (PCMH) has many key goals and components. When paneled, the majority of AMCP 2013 Nexus attendees agreed that the PCMH is best described as a practice model that organizes primary care practice operations and incentives to deliver patient-centered, coordinated, comprehensive care with the goal of improved quality and efficiency.
The patient-centered medical home (PCMH) has many key goals and components. When paneled, the majority of AMCP 2013 Nexus attendees agreed that the PCMH is best described as “a practice model that organizes primary care practice operations and incentives to deliver patient-centered, coordinated, comprehensive care with the goal of improved quality and efficiency.” With health reform, and the emergence of novel practice models, managed care organizations are increasingly identifying ways in which pharmacist involvement can help to improve the quality and cost-effectiveness of patient care.
Stephanie Ross, PharmD, BCACP, primary care clinical pharmacist, Capital District Physicians’ Health Plan, Inc (CDPHP), says that 5 years ago, CDPHP recognized that primary care was in crisis. The predicament included a projected shortage of primary care physicians, and a model of care that did not offer competitive earnings to attract the interest of graduating students. This provided incentive for CDPHP to support enhanced reimbursement to primary care practices, as well as to make the profession more attractive for medical students. Dr Ross said that one of the reasons we need pharmacists to participate in the model home is that more than 80% of treatments involve some form of medication. Furthermore, an aging population with more comorbid/complex disease will require complex individualized treatment strategies.
Beyond the triple aim, pharmacists can collaboratively support high-quality and cost-effective care in a multitude of ways. Dr Ross suggests those include chronic use of PPIs/PPI step-down protocol, proper management of common acute care illnesses, hypertension treatment education, diabetes resources, and miscellaneous drug conversions. In CDPHP’s next phase of embedding the managing clinical pharmacist into primary care practice, they hope to focus on population management/population health, expand primary care clinical pharmacy services to more medical groups, and establish best practices among providers in the community including quality, satisfaction, and cost.
Alex C. Bitting, PharmD, VRx Pharmacy Services, relayed one provider’s feedback about the importance of pharmacy involvement with the PCMH. “Having a clinical pharmacist available on site has supplemented the care I am able to provide my patients. The pharmacist is able to take time to educate patients not only on medications prescribed, but also how the body responds to each medication,” said Erica Baiden, MD, family medicine. “I also appreciate having another pair of eyes to offer my patients quality and comprehensive care.”
Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD, chief medical officer, the Access Group, added that just as pharmacists play a critical role in medication adherence, the pharmacy can also play an equal role in medication access and management. The retail pharmacy can improve timing and location of delivery, as well as play a critical role in adherence through medication dispersing services.
Dr Stefanacci says what is critical for managed care organizations is the identification of both the “right patient and the right intervention.”
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
A Focus on Women: AUA Best Posters Highlight Female Athletes, Prenatal Care, and Women in Urology
May 9th 2024Three posters from the American Urological Association (AUA) 2024 Annual Meeting focused on urinary incontinence in female athletes, prenatal care for fetuses with spina bifida in California, and the experiences of women residents at the Brady Urological Institute.
Read More